Endovascular treatment in the superficial femoral artery: which devices, where?
Endovascular interventions focused on the treatment of superficial femoral artery occlusive disease have increased exponentially as technologic advances have provided the practitioner with a wide array of treatment options. Unfortunately, there is a lack of comparative trials available to guide the practitioner in determining when these devices are best utilized. In the current report, the available comparative data, single-arm trials, and registry data are reviewed and device recommendations are proposed based on TASC II classification, lesion morphology, and indication.